Given the role of non-catalytic AKT function in cancer cell survival,19 the incorporation of this type of readout in assay cascades for the discovery or optimisation of new AKT inhibitors could prove critical in improving the therapeutic potential of AKT-targeting agents. Here, AKT1 is linked to cancer.